PORTLAND, Maine–(BUSINESS WIRE)–MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, today announced the closing of a Series B extension round, with investment from one of Japan’s largest venture capital companies Global Brain with its CVC JGC MIRAI Innovation Fund, and Bose Ventures. The follow-on investment brings the Company’s total Series B financing to $27 million, an increase from their announcement in July. Read more
MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round
Related Posts
On the Record: Startup aims to turn scientific researchers into ‘deep-tech’ entrepreneurs
Justin Hafner, founder and former CEO of digital health startup Kinotek, aims to make an even bigger splash in the startup world...
Skincare startup funds UMaine scholarship to spark innovation
Marin Skincare, known for its Lobster Lotion product, partnered with the University of Maine to create a scholarship to spur innovation and...
Bigelow Lab looks to create ‘blue’ biotechnology businesses and jobs
Bigelow Laboratory for Ocean Sciences, an East Boothbay nonprofit research institute focused on global ocean health, last week launched a program...